Adverse reactions to BNT162b2 mild, moderate for 5- to 11-year-olds
Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in
Updated on: March 19,2024
18
Adverse reactions to BNT162b2 mild, moderate for 5- to 11-year-olds
Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in
Updated on:March 19,2024
18